Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2009
03/18/2009EP2036889A2 Substituted indoles and a method for the production and use thereof
03/18/2009EP2035418A1 Novel heteroaryl substituted benzoxazoles
03/18/2009EP2035417A1 Benzimidazoles and their use for the treatemnt of diabetes
03/18/2009EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor
03/18/2009EP2035396A2 Triazole compounds that modulate hsp90 activity
03/18/2009EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
03/18/2009EP2035377A1 Indole derivatives and their use as thyroid receptor ligands
03/18/2009EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
03/18/2009EP1802311B1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c
03/18/2009EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009CN101389625A Herbicidal isoxazoline compounds
03/18/2009CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/18/2009CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants
03/18/2009CN101389608A 5-HT7 receptor antagonists
03/18/2009CN101389607A Substituted arylsulfonamides as antiviral agents
03/18/2009CN101386619A Synthesis of 3,6-bis(tetrahydro-1,3-benzoxazolinone)-9-substituted carbazole
03/18/2009CN100469779C Inhibitors of interleukin-1beta converting enzyme
03/18/2009CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases
03/18/2009CN100469770C 5-substituted-pyrazine or -pyridine glucokinase activators
03/17/2009US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases
03/17/2009US7504506 Therapeutic compounds and uses thereof
03/17/2009US7504500 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
03/17/2009US7504426 Antiallergens; rhitinis; antiinflammatory agents
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/17/2009US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
03/17/2009US7504416 4-substituted quinolines as antitumor agents
03/17/2009US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives
03/17/2009US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents
03/17/2009US7504408 Quinzoline derivatives for use in the treatment of cancer
03/17/2009US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia
03/17/2009US7504401 Anti-cancer agents and uses thereof
03/17/2009US7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
03/17/2009US7504393 Benzylamine analogues
03/17/2009US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use
03/17/2009US7504162 Heat resistance; forming film
03/17/2009CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
03/17/2009CA2328234C Compounds that inhibit the binding of integrins to their receptors
03/12/2009WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
03/12/2009WO2009032667A1 Thiazole and oxazole kinase inhibitors
03/12/2009WO2009031011A2 Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
03/12/2009WO2009030968A1 Mao a inhibitors with a diphenyl ether-substructure.
03/12/2009WO2009030316A1 1,3-dihydroisoindole derivatives
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2008012002A3 Coating of artificial surfaces of medical aids and instruments, and cleaning and/or pretreatment of catheters and other medical aids and instruments
03/12/2009WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity
03/12/2009US20090069565 New indole derivatives as factor xa inhibitors
03/12/2009US20090069559 Compositions and methods for modulating sirtuin activity
03/12/2009US20090069533 Benzoxazine monomers, polymers and compositions
03/12/2009US20090069396 Polyene Oxazoles and Processes for Their Preparation
03/12/2009US20090069383 Thrombin Receptor Antagonists
03/12/2009US20090069330 Substituted Oxazole Compounds with Analgesic Activity
03/12/2009US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/12/2009US20090069328 Alpha-alkyl substituted n-acyltryptophanols
03/12/2009US20090069327 Compounds and compositions as protein kinase inhibitors
03/12/2009US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
03/12/2009US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
03/12/2009US20090069323 11beta-hsdi inhibitors
03/12/2009US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
03/12/2009US20090069321 Cyanomethyl substituted n-acyl tryptamines
03/12/2009US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof
03/12/2009US20090069319 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
03/12/2009US20090069317 Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives
03/12/2009US20090069316 Novel quinoline derivatives
03/12/2009US20090069314 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
03/12/2009US20090069313 Novel MAO-A inhibitors
03/12/2009US20090069312 Potassium Channel Inhibitors
03/12/2009US20090069311 histamine H3-antagonists such as [5-(1-ethyl-piperidin-4-ylamino)-1H-indol-2-yl]-piperidin-1-yl-methanone, used for the treatment of obesity or eating disorders, and non-insulin dependent diabetes
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
03/12/2009US20090069303 Phthalazinone derivatives
03/12/2009US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators
03/12/2009US20090069298 Pyrazolo[1,5-A]Pyrimidine Compounds
03/12/2009US20090069283 Potassium Channel Inhibitors
03/12/2009US20090069252 C-glycoside derivatives and salts thereof
03/12/2009US20090068718 Amino acid derivatives of indolinone based protein kinase inhibitors
03/12/2009US20090068699 Use of glutaminyl cyclase inhibitors
03/12/2009US20090068577 Naphthalenetetracarboxylic acid diimide derivative and electrophotographic photoconductor having the same
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009US20090068144 Tetrahydro-isoquinolin-1-ones for the treatment of cancer
03/12/2009US20090066245 Material for light-emitting element and light emitting element
03/12/2009CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
03/12/2009CA2697934A1 1,3-dihydroisoindole derivatives
03/12/2009CA2696824A1 Compounds and compositions as kinase inhibitors
03/11/2009EP2033960A2 Linezolid crystalline hydrate form and linezolid salts
03/11/2009EP2033956A1 A new class of histone deacetylase inhibitors
03/11/2009EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2032570A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032568A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor
03/11/2009EP2032567A1 Substituted heterocycles and use thereof
03/11/2009EP2032566A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032565A2 Benzisoxazole oxazolidinones as antibacterial agents
03/11/2009EP2032541A2 Novel viral replication inhibitor
03/11/2009EP1934207B1 Substituted 4-phenyl piperidines for use as renin inhibitors
03/11/2009EP1814877B1 Diphenyl substituted alkanes as flap inhibitors
03/11/2009EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists